Boston Scientific wins big book as Bayer brings hybrid

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings
Corporate Bonds
High grade and crossover bonds

Boston Scientific wins big book as Bayer brings hybrid

Mike Turner
November 06, 2019 04:30 PM
Calendar_Fotolia_230x150

Boston Scientific Corp, the US medical devices maker, obtained plenty of demand for its €900m bond as it made its debut in the Reverse Yankee market on Wednesday, while the euro corporate bond pipeline continues to fill for a flurry of issuance in November.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

BNP ParibasMUFGBank of AmericaBarclaysCorporate BondsGoldman SachsHigh grade and crossover bonds
MT
Mike Turner
Corporate Debt Editor
Contact
Gift this article